Araştırma Makalesi

A CROSS-SECTIONAL STUDY: PERCEPTION AND CONSUMPTION BEHAVIOR ABOUT IMMUNITY BOOSTER SAMBUCUS SP. PRODUCTS (AZERBAIJAN, GEORGIA, UZBEKISTAN)

Cilt: 46 Sayı: 3 30 Eylül 2022
PDF İndir
TR EN

A CROSS-SECTIONAL STUDY: PERCEPTION AND CONSUMPTION BEHAVIOR ABOUT IMMUNITY BOOSTER SAMBUCUS SP. PRODUCTS (AZERBAIJAN, GEORGIA, UZBEKISTAN)

Öz

Objective: The aim of this cross-sectional study was to measure and determine the difference between perception and consumption changes of elderberry products in Azerbaijan (AZ), Georgia (GEO) and Uzbekistan (UZB) countries.
Material and Method: A questionnaire based, cross-sectional, multi country study was conducted by using an online based with consumers of pharmacies, drug stores and shops where had food supplement category between April and August 2021.
Result and Discussion: The majority of responders belong to 31-50 age group, and higher gender profile was on female part, 85%. The results showed that end users of consumed products were children (51%) and older family members (39%) in the average data of 3 countries. Elderberry products were classified as expensive products but were consumed high amount during the pandemic. During the pandemic, immune boosting had been in prior place of individual healthcare, and prophylactic approach had become more important than earlier. This is the first study in Azerbaijan, Georgia and Uzbekistan as a digital survey based, cross- sectional study.

Anahtar Kelimeler

Teşekkür

The author is grateful for market access of the survey to Asfarma Azerbaijan, Georgia and Uzbekistan team members.

Kaynakça

  1. 1. Schmitzer, V., Veberic, R., Stampar, R. (2012). European elderberry (Sambucus nigra L.) and American Elderberry (Sambucus canadensis L.): Botanical, chemical and health properties of flowers, berries and their products. Chapter VI, In Berries: Properties, Consumption and Nutrition; C. Tuberoso (Ed), (p.127-144). New York: Nova Science Publishers Inc.
  2. 2. Tiralongo, E., Wee, E.S, Lea, A.R. (2016). Elderberry supplementation reduces cold duration and symptoms in air-travellers: A randomized, double-blind, placebo-controlled clinical trial. Nutrients Nutrients, 8, 182-197. [CrossRef]
  3. 3. Porter, S.R., Bode, F.R. (2017). A review of the antiviral properties of Black Elder (Sambucus nigra L.) Products. Phytotheraphy Research, 31(4), 533- 554. [CrossRef]
  4. 4. Wieland, L.S., Piechotta, V., Feinberg, T., Ludeman, E., Hutton, B., Kanji, S., Seely, D. (2021). Elderberry for prevention and treatment of viral respiratory illnesses: a systematic review. BMC Complementary Medicine and Therapies, 21, 112-127. [CrossRef]
  5. 5. Kinoshita, E., Hayashi, K., Katayama, H., Hayashi, T., Obata, A. (2012). Anti-Influenza virus effects of elderberry juice and its fractions. Bioscience, Biotechnology. and Biochemistry, 76(9), 1633-1638. [CrossRef]
  6. 6. Lee, J., Finn, C.E. (2007). Anthocyanins and other polyphenolics in American Elderberry (Sambucus canadensis) and European Elderberry (S. nigra) cultivars. Journal of the Science of Food and Agriculture, 87(14), 2665-2675. [CrossRef]
  7. 7. Veberic, R., Jakopic, J., Stampar, F., Schmitzer, V. (2009). European Elderberry (Sambucus nigra L.) rich in sugars, organic acids, anthocyanins and selected polyphenols. Food Chemistry, 114(2), 511-515. [CrossRef]
  8. 8. Ferreira, S.S., Silva, P., Silva, A.M., Nunes, F.M. (2020). Effect of harvesting year and Elderberry cultivar on the chemical composition and potential bioactivity: A three-year study. Food Chemistry, 302, 125345-125366. [CrossRef]

Ayrıntılar

Birincil Dil

İngilizce

Konular

Eczacılık ve İlaç Bilimleri

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

30 Eylül 2022

Gönderilme Tarihi

10 Mayıs 2022

Kabul Tarihi

5 Temmuz 2022

Yayımlandığı Sayı

Yıl 2022 Cilt: 46 Sayı: 3

Kaynak Göster

APA
Ulusoylu-dumlu, M. (2022). A CROSS-SECTIONAL STUDY: PERCEPTION AND CONSUMPTION BEHAVIOR ABOUT IMMUNITY BOOSTER SAMBUCUS SP. PRODUCTS (AZERBAIJAN, GEORGIA, UZBEKISTAN). Journal of Faculty of Pharmacy of Ankara University, 46(3), 755-763. https://doi.org/10.33483/jfpau.1115035
AMA
1.Ulusoylu-dumlu M. A CROSS-SECTIONAL STUDY: PERCEPTION AND CONSUMPTION BEHAVIOR ABOUT IMMUNITY BOOSTER SAMBUCUS SP. PRODUCTS (AZERBAIJAN, GEORGIA, UZBEKISTAN). Ankara Ecz. Fak. Derg. 2022;46(3):755-763. doi:10.33483/jfpau.1115035
Chicago
Ulusoylu-dumlu, Melek. 2022. “A CROSS-SECTIONAL STUDY: PERCEPTION AND CONSUMPTION BEHAVIOR ABOUT IMMUNITY BOOSTER SAMBUCUS SP. PRODUCTS (AZERBAIJAN, GEORGIA, UZBEKISTAN)”. Journal of Faculty of Pharmacy of Ankara University 46 (3): 755-63. https://doi.org/10.33483/jfpau.1115035.
EndNote
Ulusoylu-dumlu M (01 Eylül 2022) A CROSS-SECTIONAL STUDY: PERCEPTION AND CONSUMPTION BEHAVIOR ABOUT IMMUNITY BOOSTER SAMBUCUS SP. PRODUCTS (AZERBAIJAN, GEORGIA, UZBEKISTAN). Journal of Faculty of Pharmacy of Ankara University 46 3 755–763.
IEEE
[1]M. Ulusoylu-dumlu, “A CROSS-SECTIONAL STUDY: PERCEPTION AND CONSUMPTION BEHAVIOR ABOUT IMMUNITY BOOSTER SAMBUCUS SP. PRODUCTS (AZERBAIJAN, GEORGIA, UZBEKISTAN)”, Ankara Ecz. Fak. Derg., c. 46, sy 3, ss. 755–763, Eyl. 2022, doi: 10.33483/jfpau.1115035.
ISNAD
Ulusoylu-dumlu, Melek. “A CROSS-SECTIONAL STUDY: PERCEPTION AND CONSUMPTION BEHAVIOR ABOUT IMMUNITY BOOSTER SAMBUCUS SP. PRODUCTS (AZERBAIJAN, GEORGIA, UZBEKISTAN)”. Journal of Faculty of Pharmacy of Ankara University 46/3 (01 Eylül 2022): 755-763. https://doi.org/10.33483/jfpau.1115035.
JAMA
1.Ulusoylu-dumlu M. A CROSS-SECTIONAL STUDY: PERCEPTION AND CONSUMPTION BEHAVIOR ABOUT IMMUNITY BOOSTER SAMBUCUS SP. PRODUCTS (AZERBAIJAN, GEORGIA, UZBEKISTAN). Ankara Ecz. Fak. Derg. 2022;46:755–763.
MLA
Ulusoylu-dumlu, Melek. “A CROSS-SECTIONAL STUDY: PERCEPTION AND CONSUMPTION BEHAVIOR ABOUT IMMUNITY BOOSTER SAMBUCUS SP. PRODUCTS (AZERBAIJAN, GEORGIA, UZBEKISTAN)”. Journal of Faculty of Pharmacy of Ankara University, c. 46, sy 3, Eylül 2022, ss. 755-63, doi:10.33483/jfpau.1115035.
Vancouver
1.Melek Ulusoylu-dumlu. A CROSS-SECTIONAL STUDY: PERCEPTION AND CONSUMPTION BEHAVIOR ABOUT IMMUNITY BOOSTER SAMBUCUS SP. PRODUCTS (AZERBAIJAN, GEORGIA, UZBEKISTAN). Ankara Ecz. Fak. Derg. 01 Eylül 2022;46(3):755-63. doi:10.33483/jfpau.1115035

Kapsam ve Amaç

Ankara Üniversitesi Eczacılık Fakültesi Dergisi, açık erişim, hakemli bir dergi olup Türkçe veya İngilizce olarak farmasötik bilimler alanındaki önemli gelişmeleri içeren orijinal araştırmalar, derlemeler ve kısa bildiriler için uluslararası bir yayım ortamıdır. Bilimsel toplantılarda sunulan bildiriler supleman özel sayısı olarak dergide yayımlanabilir. Ayrıca, tüm farmasötik alandaki gelecek ve önceki ulusal ve uluslararası bilimsel toplantılar ile sosyal aktiviteleri içerir.